An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions
Journal of Gastrointestinal and Liver Diseases · 29.03.2024 · 33 (1) · 123-130
DOI: 10.15403/jgld-5005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 29.03.2024. Verfasst von Dana Lewis. Beteiligte Einrichtung: OpenAPS, Seattle, WA, USA. dana@openaps.org. Hauptthemen laut MEDLINE: Exocrine Pancreatic Insufficiency, Pancreatitis, Diabetes Mellitus. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Exocrine pancreatic insufficiency (EPI) is frequently described as underscreened, underdiagnosed, and undertreated. The treatment for EPI is pancreatic enzyme replacement therapy (PERT), which is costly, and provider confidence in prescribing may be one barrier to reducing undertreatment. The lack of interchangeability studies for prescription PERT and/or lack of efficacy studies of over-the-counter enzyme options may be another barrier. This paper reviewed the prevalence of EPI in the general population and in co-conditions. Prevalence of EPI in the general population is commonly estimated around 10-20%, and further research is needed to evaluate EPI across all age groups and to better understand in which age group EPI becomes more prevalent, as an age effect is often seen in EPI prevalence studies. EPI is perceived to be highly correlated with certain co-conditions, and the majority (~65%) of EPI literature is related to a co-condition such as cystic fibrosis, pancreatitis, post-surgery, cancer, or diabetes. It can be estimated that 85% of literature in identified co-conditions, or 56% of total EPI literature, is on rarer co-conditions which only represent
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- OpenAPS, Seattle, WA, USA. dana@openaps.org.
Zitieren
APA
Lewis, D. (2024). An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions. Journal of Gastrointestinal and Liver Diseases, 33(1), 123-130. https://doi.org/10.15403/jgld-5005
Vancouver
Lewis D. An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions. Journal of Gastrointestinal and Liver Diseases. 2024;33(1):123-130. doi:10.15403/jgld-5005
BibTeX
@article{Lewis2024,
author = {Lewis, Dana},
title = {An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2024},
volume = {33},
number = {1},
pages = {123--130},
doi = {10.15403/jgld-5005}
}
EUVIMED